Northwell Lenox Hill Hospital in NYC becomes the first in the state to implant a motion-sparing device as an alternative to lumbar spine fusions. The TOPS
Regenerative medicine company Mesoblast Ltd. plans to raise AU$97 million (US$64.5 million) to conduct additional phase III registration trials for its allogeneic stem cell treatment for steroid-refractory acute graft-vs.-host disease and for chronic back pain, as required by the U.S. FDA.
Tampa (BLOOM) – CBD (cannabidiol) has garnered immense popularity in recent years as a potential natural remedy for various health conditions. In this article, we delve into the world of CBD to explore its healing potential, specifically focusing on pain management and anxiety relief. By understanding how CBD interacts with our bodies, we can better […]